Pricing Log in Create free account

Gossamer Bio, Inc. (GOSS) vs RenovoRx, Inc. (RNXT)

Gossamer Bio, Inc. and RenovoRx, Inc. are both Biotechnology companies. Gossamer Bio, Inc. and RenovoRx, Inc. are of similar size ($54.3M and $53.7M). Gossamer Bio, Inc. has the higher net margin (−235.0% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Gossamer Bio, Inc. leads on 10 and RenovoRx, Inc. on 4.

Valuation

Metric GOSS RNXT Biotechnology median
P/E n/m n/m 8.50
P/S 0.65 27.53 9.71
P/B n/m 6.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.99 25.16 9.21
Earnings yield (526.56%) (26.96%) (33.15%)
Free cash flow yield (469.68%) (21.95%) (25.50%)

Profitability

Metric GOSS RNXT Biotechnology median
Gross margin 100.00% 84.41% 65.16%
Operating margin (311.70%) (685.22%) 0.00%
Net margin (235.00%) (621.71%) 0.00%
Free cash flow margin (305.19%) (604.10%) 0.00%
Return on equity 178.72% (125.23%) (56.36%)
Return on assets (78.81%) (97.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOSS RNXT Biotechnology median
Revenue growth (TTM) 32.43% — 6.02%
EPS growth (last fiscal year) (200.00%) 20.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOSS RNXT Biotechnology median
Debt to equity (0.38) 0.00 0.00
Current ratio 0.53 5.74 4.72
Net debt to EBITDA (0.35) 0.56 0.96

Dividend

Metric GOSS RNXT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GOSS RNXT Biotechnology median
Market cap 54.32m 53.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack